$CLSD Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Clearside Biomedical, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Clearside Biomedical, Inc.. Get notifications about new insider transactions in Clearside Biomedical, Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 11 2021 | CLSD | Clearside Biomedic ... | Hutson Nancy J | Director | Option Exercise | A | 3.11 | 25,000 | 77,750 | 25,000 | |
| Jun 11 2021 | CLSD | Clearside Biomedic ... | EDWARDS JEFFREY L | Director | Option Exercise | A | 3.11 | 25,000 | 77,750 | 25,000 | |
| Jun 11 2021 | CLSD | Clearside Biomedic ... | Humphries William D. | Director | Option Exercise | A | 3.11 | 25,000 | 77,750 | 25,000 | |
| Jun 11 2021 | CLSD | Clearside Biomedic ... | SHAFFER CHRISTY L | Director | Option Exercise | A | 3.11 | 25,000 | 77,750 | 25,000 | |
| Mar 23 2021 | CLSD | Clearside Biomedic ... | LASEZKAY GEORGE M | CEO | Sell | S | 2.82 | 3,370 | 9,503 | 430,239 | 433.6 K to 430.2 K (-0.78 %) |
| Mar 15 2021 | CLSD | Clearside Biomedic ... | Hutson Nancy J | Director | Buy | P | 3.11 | 5,000 | 15,525 | 10,000 | 5 K to 10 K (+100.00 %) |
| Mar 15 2021 | CLSD | Clearside Biomedic ... | Hutson Nancy J | Director | Buy | P | 3.11 | 5,000 | 15,525 | 10,000 | 5 K to 10 K (+100.00 %) |
| Feb 12 2021 | CLSD | Clearside Biomedic ... | Thorp Clay | Director | Sell | S | 4.43 | 32,873 | 145,627 | 3,433,521 | 3.5 M to 3.4 M (-0.95 %) |
| Jan 20 2021 | CLSD | Clearside Biomedic ... | LASEZKAY GEORGE M | CEO | Option Exercise | A | 4.01 | 284,750 | 1,141,848 | 284,750 | |
| Jan 20 2021 | CLSD | Clearside Biomedic ... | LASEZKAY GEORGE M | CEO | Grant | A | 0.00 | 140,250 | 0 | 439,609 | 299.4 K to 439.6 K (+46.85 %) |
| Jan 20 2021 | CLSD | Clearside Biomedic ... | Deignan Charles A. | Chief Financial Off ... | Option Exercise | A | 4.01 | 195,640 | 784,516 | 195,640 | |
| Jan 20 2021 | CLSD | Clearside Biomedic ... | Deignan Charles A. | Chief Financial Off ... | Grant | A | 0.00 | 96,360 | 0 | 322,187 | 225.8 K to 322.2 K (+42.67 %) |
| Jan 20 2021 | CLSD | Clearside Biomedic ... | Ciulla Thomas | Chief Medical Offic ... | Option Exercise | A | 4.01 | 209,375 | 839,594 | 209,375 | |
| Jan 20 2021 | CLSD | Clearside Biomedic ... | Ciulla Thomas | Chief Medical Offic ... | Grant | A | 0.00 | 103,125 | 0 | 253,122 | 150 K to 253.1 K (+68.75 %) |
| Jan 07 2021 | CLSD | Clearside Biomedic ... | WHITMORE BRADFORD T | 10% Owner | Buy | P | 2.85 | 350,750 | 999,988 | 3,529,845 | 3.2 M to 3.5 M (+11.03 %) |
| Dec 23 2020 | CLSD | Clearside Biomedic ... | LASEZKAY GEORGE M | CEO | Sell | S | 2.07 | 3,330 | 6,893 | 299,359 | 302.7 K to 299.4 K (-1.10 %) |
| Dec 02 2020 | CLSD | Clearside Biomedic ... | WHITMORE BRADFORD T | 10% Owner | Buy | P | 1.95 | 53,900 | 105,051 | 3,127,900 | 3.1 M to 3.1 M (+1.75 %) |
| Nov 16 2020 | CLSD | Clearside Biomedic ... | WHITMORE BRADFORD T | 10% Owner | Buy | P | 1.69 | 62,000 | 104,929 | 3,012,000 | 3 M to 3 M (+2.10 %) |
| Sep 24 2020 | CLSD | Clearside Biomedic ... | LASEZKAY GEORGE M | CEO | Sell | S | 1.59 | 13,411 | 21,323 | 302,689 | 316.1 K to 302.7 K (-4.24 %) |
| Aug 18 2020 | CLSD | Clearside Biomedic ... | Humphries William D. | Director | Buy | P | 1.78 | 5,586 | 9,943 | 5,586 | 0 to 5.6 K |
| Aug 13 2020 | CLSD | Clearside Biomedic ... | WHITMORE BRADFORD T | 10% Owner | Buy | P | 1.65 | 50,000 | 82,560 | 2,950,000 | 2.9 M to 3 M (+1.72 %) |
| Aug 13 2020 | CLSD | Clearside Biomedic ... | WHITMORE BRADFORD T | 10% Owner | Buy | P | 1.63 | 300,000 | 489,120 | 2,900,000 | 2.6 M to 2.9 M (+11.54 %) |
| Jun 19 2020 | CLSD | Clearside Biomedic ... | Thorp Clay | Director | Option Exercise | A | 2.00 | 25,000 | 50,000 | 25,000 | |
| Jun 19 2020 | CLSD | Clearside Biomedic ... | SHAFFER CHRISTY L | Director | Option Exercise | A | 2.00 | 25,000 | 50,000 | 25,000 | |
| Jun 19 2020 | CLSD | Clearside Biomedic ... | EDWARDS JEFFREY L | Director | Option Exercise | A | 2.00 | 25,000 | 50,000 | 25,000 | |
| Jun 19 2020 | CLSD | Clearside Biomedic ... | Croarkin Richard | Director | Option Exercise | A | 2.00 | 25,000 | 50,000 | 25,000 | |
| Jun 19 2020 | CLSD | Clearside Biomedic ... | Humphries William D. | Director | Option Exercise | A | 2.00 | 25,000 | 50,000 | 25,000 | |
| Jun 19 2020 | CLSD | Clearside Biomedic ... | Hutson Nancy J | Director | Option Exercise | A | 2.00 | 25,000 | 50,000 | 25,000 | |
| Jun 03 2020 | CLSD | Clearside Biomedic ... | Deignan Charles A. | Chief Financial Off ... | Sell | S | 1.88 | 14,992 | 28,185 | 220,827 | 235.8 K to 220.8 K (-6.36 %) |
| May 21 2020 | CLSD | Clearside Biomedic ... | Hutson Nancy J | Director | Buy | P | 1.85 | 5,000 | 9,250 | 5,000 | 0 to 5 K |
| May 13 2020 | CLSD | Clearside Biomedic ... | LASEZKAY GEORGE M | CEO | Sell | S | 1.99 | 32,150 | 63,979 | 311,100 | 343.3 K to 311.1 K (-9.37 %) |
| Apr 23 2020 | CLSD | Clearside Biomedic ... | Hutson Nancy J | Director | Option Exercise | A | 2.09 | 30,000 | 62,700 | 30,000 | |
| Mar 13 2020 | CLSD | Clearside Biomedic ... | LASEZKAY GEORGE M | CEO | Grant | A | 0.00 | 50,000 | 0 | 343,250 | 293.3 K to 343.3 K (+17.05 %) |
| Jan 10 2020 | CLSD | Clearside Biomedic ... | Deignan Charles A. | Chief Financial Off ... | Option Exercise | A | 2.37 | 75,000 | 177,750 | 75,000 | |
| Jan 10 2020 | CLSD | Clearside Biomedic ... | Deignan Charles A. | Chief Financial Off ... | Grant | A | 0.00 | 25,000 | 0 | 228,856 | 203.9 K to 228.9 K (+12.26 %) |
| Jan 10 2020 | CLSD | Clearside Biomedic ... | LASEZKAY GEORGE M | CEO | Option Exercise | A | 2.37 | 198,750 | 471,038 | 198,750 | |
| Jan 10 2020 | CLSD | Clearside Biomedic ... | LASEZKAY GEORGE M | CEO | Grant | A | 0.00 | 66,250 | 0 | 288,250 | 222 K to 288.3 K (+29.84 %) |
| Jan 10 2020 | CLSD | Clearside Biomedic ... | Deignan Charles A. | Chief Financial Off ... | Option Exercise | A | 2.37 | 75,000 | 177,750 | 75,000 | |
| Jan 10 2020 | CLSD | Clearside Biomedic ... | Deignan Charles A. | Chief Financial Off ... | Grant | A | 0.00 | 25,000 | 0 | 228,856 | 203.9 K to 228.9 K (+12.26 %) |
| Jan 10 2020 | CLSD | Clearside Biomedic ... | LASEZKAY GEORGE M | CEO | Option Exercise | A | 2.37 | 198,750 | 471,038 | 198,750 | |
| Jan 10 2020 | CLSD | Clearside Biomedic ... | LASEZKAY GEORGE M | CEO | Grant | A | 0.00 | 66,250 | 0 | 288,250 | 222 K to 288.3 K (+29.84 %) |
| Nov 26 2019 | CLSD | Clearside Biomedic ... | Thorp Clay | Director | Grant | A | 1.05 | 1,518,026 | 1,599,999 | 4,984,420 | 3.5 M to 5 M (+43.79 %) |
| Nov 13 2019 | CLSD | Clearside Biomedic ... | Deignan Charles A. | Chief Financial Off ... | Buy | P | 1.14 | 7,500 | 8,550 | 203,856 | 196.4 K to 203.9 K (+3.82 %) |
| Nov 12 2019 | CLSD | Clearside Biomedic ... | LASEZKAY GEORGE M | CEO | Buy | P | 1.16 | 12,000 | 13,920 | 222,000 | 210 K to 222 K (+5.71 %) |
| Sep 20 2019 | CLSD | Clearside Biomedic ... | LASEZKAY GEORGE M | CEO | Grant | A | 0.00 | 110,000 | 0 | 210,000 | 100 K to 210 K (+110.00 %) |
| Sep 20 2019 | CLSD | Clearside Biomedic ... | Deignan Charles A. | Chief Financial Off ... | Grant | A | 0.00 | 70,000 | 0 | 196,356 | 126.4 K to 196.4 K (+55.40 %) |
| Aug 08 2019 | CLSD | Clearside Biomedic ... | LASEZKAY GEORGE M | CEO | Grant | A | 0.00 | 100,000 | 0 | 100,000 | 0 to 100 K |
| Jun 24 2019 | CLSD | Clearside Biomedic ... | SHAFFER CHRISTY L | Director | Option Exercise | A | 1.07 | 20,000 | 21,400 | 20,000 | |
| Jun 24 2019 | CLSD | Clearside Biomedic ... | Thorp Clay | Director | Option Exercise | A | 1.07 | 20,000 | 21,400 | 20,000 | |
| Jun 24 2019 | CLSD | Clearside Biomedic ... | Humphries William D. | Director | Option Exercise | A | 1.07 | 20,000 | 21,400 | 20,000 | |
| Jun 24 2019 | CLSD | Clearside Biomedic ... | EDWARDS JEFFREY L | Director | Option Exercise | A | 1.07 | 20,000 | 21,400 | 20,000 | |
| Jun 24 2019 | CLSD | Clearside Biomedic ... | Croarkin Richard | Director | Option Exercise | A | 1.07 | 20,000 | 21,400 | 20,000 | |
| Jun 04 2019 | CLSD | Clearside Biomedic ... | Raymond Brion S. | Chief Commercial Of ... | Grant | A | 0.00 | 50,000 | 0 | 50,000 | 0 to 50 K |
| Jun 04 2019 | CLSD | Clearside Biomedic ... | Deignan Charles A. | Chief Financial Off ... | Grant | A | 0.00 | 50,000 | 0 | 126,356 | 76.4 K to 126.4 K (+65.48 %) |
| Apr 10 2019 | CLSD | Clearside Biomedic ... | LASEZKAY GEORGE M | Interim CEO | Option Exercise | A | 1.40 | 250,000 | 350,000 | 250,000 | |
| Mar 18 2019 | CLSD | Clearside Biomedic ... | Deignan Charles A. | Chief Financial Off ... | Buy | P | 1.36 | 10,000 | 13,600 | 76,356 | 66.4 K to 76.4 K (+15.07 %) |
| Feb 07 2019 | CLSD | Clearside Biomedic ... | White Daniel H. | President and CEO | Option Exercise | A | 1.24 | 200,000 | 248,000 | 200,000 | |
| Feb 07 2019 | CLSD | Clearside Biomedic ... | Raymond Brion S. | Chief Commercial Of ... | Option Exercise | A | 1.24 | 100,000 | 124,000 | 100,000 | |
| Feb 07 2019 | CLSD | Clearside Biomedic ... | Deignan Charles A. | Chief Financial Off ... | Option Exercise | A | 1.24 | 100,000 | 124,000 | 100,000 | |
| Dec 06 2018 | CLSD | Clearside Biomedic ... | Thorp Clay | Director | Buy | P | 1.36 | 8,000 | 10,880 | 8,000 | 0 to 8 K |
| Sep 28 2018 | CLSD | Clearside Biomedic ... | EDWARDS JEFFREY L | Director | Option Exercise | A | 6.03 | 22,500 | 135,675 | 22,500 | |
| Jun 26 2018 | CLSD | Clearside Biomedic ... | Cagle Gerald D. | Director | Option Exercise | M | 9.11 | 2,632 | 23,978 | 0 | |
| Jun 26 2018 | CLSD | Clearside Biomedic ... | Cagle Gerald D. | Director | Option Exercise | M | 8.81 | 8,618 | 75,925 | 0 | |
| Jun 26 2018 | CLSD | Clearside Biomedic ... | Cagle Gerald D. | Director | Buy | M | 9.11 | 2,632 | 23,978 | 80,145 | 77.5 K to 80.1 K (+3.40 %) |
| Jun 26 2018 | CLSD | Clearside Biomedic ... | Cagle Gerald D. | Director | Buy | M | 8.81 | 8,618 | 75,925 | 77,513 | 68.9 K to 77.5 K (+12.51 %) |
| Jun 21 2018 | CLSD | Clearside Biomedic ... | Zaytsev Evgeny | Director | Option Exercise | A | 10.74 | 11,250 | 120,825 | 11,250 | |
| Jun 21 2018 | CLSD | Clearside Biomedic ... | Thorp Clay | Director | Option Exercise | A | 10.74 | 11,250 | 120,825 | 11,250 | |
| Jun 21 2018 | CLSD | Clearside Biomedic ... | SHAFFER CHRISTY L | Director | Option Exercise | A | 10.74 | 11,250 | 120,825 | 11,250 | |
| Jun 21 2018 | CLSD | Clearside Biomedic ... | LASEZKAY GEORGE M | Director | Option Exercise | A | 10.74 | 11,250 | 120,825 | 11,250 | |
| Jun 21 2018 | CLSD | Clearside Biomedic ... | Humphries William D. | Director | Option Exercise | A | 10.74 | 11,250 | 120,825 | 11,250 | |
| Jun 21 2018 | CLSD | Clearside Biomedic ... | Croarkin Richard | Director | Option Exercise | A | 10.74 | 11,250 | 120,825 | 11,250 | |
| Jun 21 2018 | CLSD | Clearside Biomedic ... | Cagle Gerald D. | Director | Option Exercise | A | 10.74 | 11,250 | 120,825 | 11,250 | |
| Jun 04 2018 | CLSD | Clearside Biomedic ... | White Daniel H. | President and CEO | Buy | P | 9.07 | 11,000 | 99,770 | 483,335 | 472.3 K to 483.3 K (+2.33 %) |
| Jun 04 2018 | CLSD | Clearside Biomedic ... | White Daniel H. | President and CEO | Gift | G | 0.00 | 2,000 | 0 | 472,335 | 474.3 K to 472.3 K (-0.42 %) |
| May 21 2018 | CLSD | Clearside Biomedic ... | Thorp Clay | Director | Sell | S | 13.16 | 61,139 | 804,589 | 3,466,394 | 3.5 M to 3.5 M (-1.73 %) |
| May 21 2018 | CLSD | Clearside Biomedic ... | Thorp Clay | Director | Sell | S | 13.03 | 100,000 | 1,303,000 | 3,527,533 | 3.6 M to 3.5 M (-2.76 %) |
| May 15 2018 | CLSD | Clearside Biomedic ... | Cagle Gerald D. | Director | Option Exercise | M | 0.40 | 45,454 | 18,182 | 0 | |
| May 15 2018 | CLSD | Clearside Biomedic ... | Cagle Gerald D. | Director | Buy | M | 0.40 | 45,454 | 18,182 | 68,895 | 23.4 K to 68.9 K (+193.91 %) |
| Mar 26 2018 | CLSD | Clearside Biomedic ... | Deignan Charles A. | Chief Financial Off ... | Buy | P | 11.79 | 500 | 5,895 | 66,356 | 65.9 K to 66.4 K (+0.76 %) |
| Mar 23 2018 | CLSD | Clearside Biomedic ... | Thorp Clay | Director | Sell | S | 12.02 | 5,231 | 62,877 | 3,627,533 | 3.6 M to 3.6 M (-0.14 %) |
| Mar 23 2018 | CLSD | Clearside Biomedic ... | Thorp Clay | Director | Sell | S | 12.02 | 5,231 | 62,877 | 3,627,533 | 3.6 M to 3.6 M (-0.14 %) |
| Mar 23 2018 | CLSD | Clearside Biomedic ... | Thorp Clay | Director | Sell | S | 12.07 | 33,630 | 405,914 | 3,632,764 | 3.7 M to 3.6 M (-0.92 %) |
| Mar 23 2018 | CLSD | Clearside Biomedic ... | Thorp Clay | Director | Sell | S | 12.07 | 33,630 | 405,914 | 3,632,764 | 3.7 M to 3.6 M (-0.92 %) |
| Mar 23 2018 | CLSD | Clearside Biomedic ... | Thorp Clay | Director | Sell | S | 12.27 | 100,000 | 1,227,000 | 3,666,394 | 3.8 M to 3.7 M (-2.66 %) |
| Mar 23 2018 | CLSD | Clearside Biomedic ... | Thorp Clay | Director | Sell | S | 12.27 | 100,000 | 1,227,000 | 3,666,394 | 3.8 M to 3.7 M (-2.66 %) |
| Mar 23 2018 | CLSD | Clearside Biomedic ... | Cagle Gerald D. | Director | Buy | P | 11.89 | 7,500 | 89,175 | 23,441 | 15.9 K to 23.4 K (+47.05 %) |
| Feb 27 2018 | CLSD | Clearside Biomedic ... | Raymond Brion S. | Chief Commercial Of ... | Option Exercise | A | 6.23 | 80,000 | 498,400 | 80,000 | |
| Dec 12 2017 | CLSD | Clearside Biomedic ... | Noronha Glenn | Chief Scientific Of ... | Option Exercise | A | 5.89 | 96,000 | 565,440 | 96,000 | |
| Dec 12 2017 | CLSD | Clearside Biomedic ... | White Daniel H. | President and CEO | Option Exercise | A | 5.89 | 221,500 | 1,304,635 | 221,500 | |
| Dec 12 2017 | CLSD | Clearside Biomedic ... | Deignan Charles A. | Chief Financial Off ... | Option Exercise | A | 5.89 | 96,000 | 565,440 | 96,000 | |
| Dec 07 2017 | CLSD | Clearside Biomedic ... | Thorp Clay | Director | Sell | S | 6.13 | 5,000 | 30,650 | 3,766,394 | 3.8 M to 3.8 M (-0.13 %) |
| Dec 07 2017 | CLSD | Clearside Biomedic ... | Thorp Clay | Director | Sell | S | 6.09 | 15,000 | 91,350 | 3,771,394 | 3.8 M to 3.8 M (-0.40 %) |
| Dec 07 2017 | CLSD | Clearside Biomedic ... | Thorp Clay | Director | Sell | S | 6.37 | 15,000 | 95,550 | 3,786,394 | 3.8 M to 3.8 M (-0.39 %) |
| Nov 16 2017 | CLSD | Clearside Biomedic ... | Thorp Clay | Director | Sell | S | 6.99 | 5,000 | 34,950 | 3,801,394 | 3.8 M to 3.8 M (-0.13 %) |
| Nov 16 2017 | CLSD | Clearside Biomedic ... | Thorp Clay | Director | Sell | S | 6.99 | 15,000 | 104,850 | 3,806,394 | 3.8 M to 3.8 M (-0.39 %) |
| Nov 16 2017 | CLSD | Clearside Biomedic ... | Thorp Clay | Director | Sell | S | 7.02 | 15,000 | 105,300 | 3,821,394 | 3.8 M to 3.8 M (-0.39 %) |
| Oct 23 2017 | CLSD | Clearside Biomedic ... | White Daniel H. | President and CEO | Sell | S | 7.81 | 400 | 3,124 | 35,309 | 35.7 K to 35.3 K (-1.12 %) |
| Oct 23 2017 | CLSD | Clearside Biomedic ... | White Daniel H. | President and CEO | Sell | S | 7.82 | 400 | 3,128 | 35,709 | 36.1 K to 35.7 K (-1.11 %) |
| Oct 23 2017 | CLSD | Clearside Biomedic ... | White Daniel H. | President and CEO | Sell | S | 7.81 | 3,600 | 28,116 | 474,335 | 477.9 K to 474.3 K (-0.75 %) |
| Oct 23 2017 | CLSD | Clearside Biomedic ... | White Daniel H. | President and CEO | Sell | S | 7.82 | 3,600 | 28,152 | 477,935 | 481.5 K to 477.9 K (-0.75 %) |
| Oct 05 2017 | CLSD | Clearside Biomedic ... | Thorp Clay | Director | Sell | S | 8.34 | 6,000 | 50,040 | 3,836,394 | 3.8 M to 3.8 M (-0.16 %) |
| Oct 05 2017 | CLSD | Clearside Biomedic ... | Thorp Clay | Director | Sell | S | 8.59 | 14,000 | 120,260 | 3,842,394 | 3.9 M to 3.8 M (-0.36 %) |
| Oct 05 2017 | CLSD | Clearside Biomedic ... | Thorp Clay | Director | Sell | S | 8.64 | 15,000 | 129,600 | 3,856,394 | 3.9 M to 3.9 M (-0.39 %) |
| Sep 15 2017 | CLSD | Clearside Biomedic ... | Thorp Clay | Director | Sell | S | 7.54 | 10,000 | 75,400 | 3,871,394 | 3.9 M to 3.9 M (-0.26 %) |
| Sep 15 2017 | CLSD | Clearside Biomedic ... | Thorp Clay | Director | Sell | S | 7.52 | 6,000 | 45,120 | 3,881,394 | 3.9 M to 3.9 M (-0.15 %) |
| Sep 15 2017 | CLSD | Clearside Biomedic ... | Thorp Clay | Director | Sell | S | 7.49 | 8,500 | 63,665 | 3,887,394 | 3.9 M to 3.9 M (-0.22 %) |
| Sep 11 2017 | CLSD | Clearside Biomedic ... | White Daniel H. | President and CEO | Sell | S | 7.63 | 600 | 4,578 | 36,109 | 36.7 K to 36.1 K (-1.63 %) |
| Sep 11 2017 | CLSD | Clearside Biomedic ... | White Daniel H. | President and CEO | Sell | S | 7.53 | 1,000 | 7,530 | 36,709 | 37.7 K to 36.7 K (-2.65 %) |
| Sep 11 2017 | CLSD | Clearside Biomedic ... | White Daniel H. | President and CEO | Sell | S | 7.63 | 5,400 | 41,202 | 481,535 | 486.9 K to 481.5 K (-1.11 %) |
| Sep 11 2017 | CLSD | Clearside Biomedic ... | White Daniel H. | President and CEO | Sell | S | 7.53 | 9,000 | 67,770 | 486,935 | 495.9 K to 486.9 K (-1.81 %) |
| Aug 16 2017 | CLSD | Clearside Biomedic ... | SHAFFER CHRISTY L | Director | Buy | P | 7.00 | 1,100 | 7,700 | 4,400 | 3.3 K to 4.4 K (+33.33 %) |
| Aug 15 2017 | CLSD | Clearside Biomedic ... | Cagle Gerald D. | Director | Buy | P | 7.08 | 5,000 | 35,400 | 15,941 | 10.9 K to 15.9 K (+45.70 %) |
| Aug 14 2017 | CLSD | Clearside Biomedic ... | Deignan Charles A. | Chief Financial Off ... | Buy | P | 7.07 | 1,000 | 7,065 | 65,309 | 64.3 K to 65.3 K (+1.55 %) |
| Aug 10 2017 | CLSD | Clearside Biomedic ... | LASEZKAY GEORGE M | Director | Option Exercise | A | 7.96 | 22,500 | 179,100 | 22,500 | |
| Aug 09 2017 | CLSD | Clearside Biomedic ... | Thorp Clay | Director | Sell | S | 7.30 | 15,000 | 109,500 | 3,895,894 | 3.9 M to 3.9 M (-0.38 %) |
| Aug 09 2017 | CLSD | Clearside Biomedic ... | Thorp Clay | Director | Sell | S | 7.98 | 5,000 | 39,900 | 3,910,894 | 3.9 M to 3.9 M (-0.13 %) |
| Aug 09 2017 | CLSD | Clearside Biomedic ... | Thorp Clay | Director | Sell | S | 8.02 | 4,500 | 36,090 | 3,915,894 | 3.9 M to 3.9 M (-0.11 %) |
| Jul 21 2017 | CLSD | Clearside Biomedic ... | White Daniel H. | President and CEO | Sell | S | 9.71 | 400 | 3,884 | 37,709 | 38.1 K to 37.7 K (-1.05 %) |
| Jul 21 2017 | CLSD | Clearside Biomedic ... | White Daniel H. | President and CEO | Sell | S | 9.79 | 400 | 3,916 | 38,109 | 38.5 K to 38.1 K (-1.04 %) |
| Jul 21 2017 | CLSD | Clearside Biomedic ... | White Daniel H. | President and CEO | Sell | S | 9.71 | 3,600 | 34,956 | 496,367 | 500 K to 496.4 K (-0.72 %) |
| Jul 21 2017 | CLSD | Clearside Biomedic ... | White Daniel H. | President and CEO | Sell | S | 9.79 | 3,600 | 35,244 | 499,967 | 503.6 K to 500 K (-0.71 %) |
| Jul 05 2017 | CLSD | Clearside Biomedic ... | Croarkin Richard | Director | Option Exercise | A | 9.11 | 2,632 | 23,978 | 2,632 | |
| Jul 05 2017 | CLSD | Clearside Biomedic ... | SHAFFER CHRISTY L | Director | Option Exercise | A | 9.11 | 2,632 | 23,978 | 2,632 | |
| Jun 23 2017 | CLSD | Clearside Biomedic ... | Zaytsev Evgeny | Director | Option Exercise | A | 8.81 | 8,618 | 75,925 | 8,618 | |
| Jun 23 2017 | CLSD | Clearside Biomedic ... | Yoon Derek | Director | Option Exercise | A | 8.81 | 8,618 | 75,925 | 8,618 | |
| Jun 23 2017 | CLSD | Clearside Biomedic ... | Thorp Clay | Director | Option Exercise | A | 8.81 | 8,618 | 75,925 | 8,618 | |
| Jun 23 2017 | CLSD | Clearside Biomedic ... | Humphries William D. | Director | Option Exercise | A | 8.81 | 8,618 | 75,925 | 8,618 | |
| Jun 23 2017 | CLSD | Clearside Biomedic ... | Croarkin Richard | Director | Option Exercise | A | 8.81 | 8,618 | 75,925 | 8,618 | |
| Jun 23 2017 | CLSD | Clearside Biomedic ... | Cagle Gerald D. | Director | Option Exercise | A | 8.81 | 8,618 | 75,925 | 8,618 | |
| Jun 23 2017 | CLSD | Clearside Biomedic ... | SHAFFER CHRISTY L | Director | Option Exercise | A | 8.81 | 8,618 | 75,925 | 8,618 | |
| Jun 14 2017 | CLSD | Clearside Biomedic ... | White Daniel H. | President and CEO | Sell | S | 7.99 | 400 | 3,196 | 38,509 | 38.9 K to 38.5 K (-1.03 %) |
| Jun 14 2017 | CLSD | Clearside Biomedic ... | White Daniel H. | President and CEO | Sell | S | 7.78 | 400 | 3,112 | 38,909 | 39.3 K to 38.9 K (-1.02 %) |
| Jun 14 2017 | CLSD | Clearside Biomedic ... | White Daniel H. | President and CEO | Sell | S | 7.99 | 3,600 | 28,764 | 500,467 | 504.1 K to 500.5 K (-0.71 %) |
| Jun 14 2017 | CLSD | Clearside Biomedic ... | White Daniel H. | President and CEO | Sell | S | 7.78 | 3,600 | 28,008 | 504,067 | 507.7 K to 504.1 K (-0.71 %) |
| May 23 2017 | CLSD | Clearside Biomedic ... | SHAFFER CHRISTY L | Director | Buy | P | 8.00 | 1,100 | 8,800 | 3,300 | 2.2 K to 3.3 K (+50.00 %) |
| May 19 2017 | CLSD | Clearside Biomedic ... | Thorp Clay | Director | Sell | S | 8.31 | 15,000 | 124,650 | 3,920,394 | 3.9 M to 3.9 M (-0.38 %) |
| May 19 2017 | CLSD | Clearside Biomedic ... | Thorp Clay | Director | Sell | S | 8.44 | 9,000 | 75,960 | 3,935,394 | 3.9 M to 3.9 M (-0.23 %) |
| May 19 2017 | CLSD | Clearside Biomedic ... | White Daniel H. | President and CEO | Sell | S | 8.44 | 400 | 3,376 | 39,309 | 39.7 K to 39.3 K (-1.01 %) |
| May 19 2017 | CLSD | Clearside Biomedic ... | White Daniel H. | President and CEO | Sell | S | 8.38 | 400 | 3,352 | 39,709 | 40.1 K to 39.7 K (-1.00 %) |
| May 19 2017 | CLSD | Clearside Biomedic ... | White Daniel H. | President and CEO | Sell | S | 8.44 | 3,600 | 30,384 | 507,667 | 511.3 K to 507.7 K (-0.70 %) |
| May 19 2017 | CLSD | Clearside Biomedic ... | White Daniel H. | President and CEO | Sell | S | 8.38 | 3,600 | 30,168 | 511,267 | 514.9 K to 511.3 K (-0.70 %) |
| May 17 2017 | CLSD | Clearside Biomedic ... | Thorp Clay | Director | Sell | S | 8.39 | 19,000 | 159,410 | 3,944,394 | 4 M to 3.9 M (-0.48 %) |
| May 17 2017 | CLSD | Clearside Biomedic ... | Thorp Clay | Director | Sell | S | 8.61 | 9,544 | 82,174 | 3,963,394 | 4 M to 4 M (-0.24 %) |
| May 17 2017 | CLSD | Clearside Biomedic ... | Thorp Clay | Director | Sell | S | 8.94 | 15,941 | 142,513 | 3,972,938 | 4 M to 4 M (-0.40 %) |
| May 01 2017 | CLSD | Clearside Biomedic ... | Cagle Gerald D. | Director | Buy | P | 7.10 | 14,064 | 99,854 | 14,064 | 0 to 14.1 K |
| Apr 19 2017 | CLSD | Clearside Biomedic ... | Thorp Clay | Director | Sell | S | 7.37 | 2,030 | 14,961 | 3,988,879 | 4 M to 4 M (-0.05 %) |
| Apr 19 2017 | CLSD | Clearside Biomedic ... | Thorp Clay | Director | Sell | S | 7.48 | 44,455 | 332,523 | 3,990,909 | 4 M to 4 M (-1.10 %) |
| Apr 19 2017 | CLSD | Clearside Biomedic ... | Thorp Clay | Director | Sell | S | 7.43 | 22,000 | 163,460 | 4,035,364 | 4.1 M to 4 M (-0.54 %) |
| Apr 05 2017 | CLSD | Clearside Biomedic ... | White Daniel H. | President and CEO | Sell | S | 7.54 | 400 | 3,016 | 40,109 | 40.5 K to 40.1 K (-0.99 %) |
| Apr 05 2017 | CLSD | Clearside Biomedic ... | White Daniel H. | President and CEO | Sell | S | 7.56 | 400 | 3,024 | 40,509 | 40.9 K to 40.5 K (-0.98 %) |